Cargando…

A new interdisciplinary treatment strategy versus usual medical care for the treatment of subacromial impingement syndrome: a randomized controlled trial

BACKGROUND: Subacromial impingement syndrome (SIS) is the most frequently recorded shoulder disorder. When conservative treatment of SIS fails, a subacromial decompression is warranted. However, the best moment of referral for surgery is not well defined. Both early and late referrals have disadvant...

Descripción completa

Detalles Bibliográficos
Autores principales: Dorrestijn, Oscar, Stevens, Martin, Diercks, Ron L, van der Meer, Klaas, Winters, Jan C
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2007
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1821022/
https://www.ncbi.nlm.nih.gov/pubmed/17316441
http://dx.doi.org/10.1186/1471-2474-8-15
_version_ 1782132669156425728
author Dorrestijn, Oscar
Stevens, Martin
Diercks, Ron L
van der Meer, Klaas
Winters, Jan C
author_facet Dorrestijn, Oscar
Stevens, Martin
Diercks, Ron L
van der Meer, Klaas
Winters, Jan C
author_sort Dorrestijn, Oscar
collection PubMed
description BACKGROUND: Subacromial impingement syndrome (SIS) is the most frequently recorded shoulder disorder. When conservative treatment of SIS fails, a subacromial decompression is warranted. However, the best moment of referral for surgery is not well defined. Both early and late referrals have disadvantages – unnecessary operations and smaller improvements in shoulder function, respectively. This paper describes the design of a new interdisciplinary treatment strategy for SIS (TRANSIT), which comprises rules to treat SIS in primary care and a well-defined moment of referral for surgery. METHODS/DESIGN: The effectiveness of an arthroscopic subacromial decompression versus usual medical care will be evaluated in a randomized controlled trial (RCT). Patients are eligible for inclusion when experiencing a recurrence of SIS within one year after a first episode of SIS which was successfully treated with a subacromial corticosteroid injection. After inclusion they will receive injection treatment again by their general practitioner. When, after this treatment, there is a second recurrence within a year post-injection, the participants will be randomized to either an arthroscopic subacromial decompression (intervention group) or continuation of usual medical care (control group). The latter will be performed by a general practitioner according to the Dutch National Guidelines for Shoulder Problems. At inclusion, at randomization and three, six and 12 months post-randomization an outcome assessment will take place. The primary outcome measure is the patient-reported Shoulder Disability Questionnaire. The secondary outcome measures include both disease-specific and generic measures, and an economic evaluation. Treatment effects will be compared for all measurement points by using a GLM repeated measures analyses. DISCUSSION: The rationale and design of an RCT comparing arthroscopic subacromial decompression with usual medical care for subacromial impingement syndrome are presented. The results of this study will improve insight into the best moment of referral for surgery for SIS.
format Text
id pubmed-1821022
institution National Center for Biotechnology Information
language English
publishDate 2007
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-18210222007-03-14 A new interdisciplinary treatment strategy versus usual medical care for the treatment of subacromial impingement syndrome: a randomized controlled trial Dorrestijn, Oscar Stevens, Martin Diercks, Ron L van der Meer, Klaas Winters, Jan C BMC Musculoskelet Disord Study Protocol BACKGROUND: Subacromial impingement syndrome (SIS) is the most frequently recorded shoulder disorder. When conservative treatment of SIS fails, a subacromial decompression is warranted. However, the best moment of referral for surgery is not well defined. Both early and late referrals have disadvantages – unnecessary operations and smaller improvements in shoulder function, respectively. This paper describes the design of a new interdisciplinary treatment strategy for SIS (TRANSIT), which comprises rules to treat SIS in primary care and a well-defined moment of referral for surgery. METHODS/DESIGN: The effectiveness of an arthroscopic subacromial decompression versus usual medical care will be evaluated in a randomized controlled trial (RCT). Patients are eligible for inclusion when experiencing a recurrence of SIS within one year after a first episode of SIS which was successfully treated with a subacromial corticosteroid injection. After inclusion they will receive injection treatment again by their general practitioner. When, after this treatment, there is a second recurrence within a year post-injection, the participants will be randomized to either an arthroscopic subacromial decompression (intervention group) or continuation of usual medical care (control group). The latter will be performed by a general practitioner according to the Dutch National Guidelines for Shoulder Problems. At inclusion, at randomization and three, six and 12 months post-randomization an outcome assessment will take place. The primary outcome measure is the patient-reported Shoulder Disability Questionnaire. The secondary outcome measures include both disease-specific and generic measures, and an economic evaluation. Treatment effects will be compared for all measurement points by using a GLM repeated measures analyses. DISCUSSION: The rationale and design of an RCT comparing arthroscopic subacromial decompression with usual medical care for subacromial impingement syndrome are presented. The results of this study will improve insight into the best moment of referral for surgery for SIS. BioMed Central 2007-02-22 /pmc/articles/PMC1821022/ /pubmed/17316441 http://dx.doi.org/10.1186/1471-2474-8-15 Text en Copyright © 2007 Dorrestijn et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Study Protocol
Dorrestijn, Oscar
Stevens, Martin
Diercks, Ron L
van der Meer, Klaas
Winters, Jan C
A new interdisciplinary treatment strategy versus usual medical care for the treatment of subacromial impingement syndrome: a randomized controlled trial
title A new interdisciplinary treatment strategy versus usual medical care for the treatment of subacromial impingement syndrome: a randomized controlled trial
title_full A new interdisciplinary treatment strategy versus usual medical care for the treatment of subacromial impingement syndrome: a randomized controlled trial
title_fullStr A new interdisciplinary treatment strategy versus usual medical care for the treatment of subacromial impingement syndrome: a randomized controlled trial
title_full_unstemmed A new interdisciplinary treatment strategy versus usual medical care for the treatment of subacromial impingement syndrome: a randomized controlled trial
title_short A new interdisciplinary treatment strategy versus usual medical care for the treatment of subacromial impingement syndrome: a randomized controlled trial
title_sort new interdisciplinary treatment strategy versus usual medical care for the treatment of subacromial impingement syndrome: a randomized controlled trial
topic Study Protocol
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1821022/
https://www.ncbi.nlm.nih.gov/pubmed/17316441
http://dx.doi.org/10.1186/1471-2474-8-15
work_keys_str_mv AT dorrestijnoscar anewinterdisciplinarytreatmentstrategyversususualmedicalcareforthetreatmentofsubacromialimpingementsyndromearandomizedcontrolledtrial
AT stevensmartin anewinterdisciplinarytreatmentstrategyversususualmedicalcareforthetreatmentofsubacromialimpingementsyndromearandomizedcontrolledtrial
AT diercksronl anewinterdisciplinarytreatmentstrategyversususualmedicalcareforthetreatmentofsubacromialimpingementsyndromearandomizedcontrolledtrial
AT vandermeerklaas anewinterdisciplinarytreatmentstrategyversususualmedicalcareforthetreatmentofsubacromialimpingementsyndromearandomizedcontrolledtrial
AT wintersjanc anewinterdisciplinarytreatmentstrategyversususualmedicalcareforthetreatmentofsubacromialimpingementsyndromearandomizedcontrolledtrial
AT dorrestijnoscar newinterdisciplinarytreatmentstrategyversususualmedicalcareforthetreatmentofsubacromialimpingementsyndromearandomizedcontrolledtrial
AT stevensmartin newinterdisciplinarytreatmentstrategyversususualmedicalcareforthetreatmentofsubacromialimpingementsyndromearandomizedcontrolledtrial
AT diercksronl newinterdisciplinarytreatmentstrategyversususualmedicalcareforthetreatmentofsubacromialimpingementsyndromearandomizedcontrolledtrial
AT vandermeerklaas newinterdisciplinarytreatmentstrategyversususualmedicalcareforthetreatmentofsubacromialimpingementsyndromearandomizedcontrolledtrial
AT wintersjanc newinterdisciplinarytreatmentstrategyversususualmedicalcareforthetreatmentofsubacromialimpingementsyndromearandomizedcontrolledtrial